Smith & Nephew Unveils CEO Succession Plan, Cost-Cutting Measures
This article was originally published in The Gray Sheet
Executive Summary
Incoming Smith & Nephew CEO David Illingworth's top priority will be a cost-cutting strategy to improve profit margins by an average of 1% annually through 2010
You may also be interested in...
S&N’s BlueSky Purchase Puts Negative Pressure On Kinetic Concepts
Smith & Nephew's entry into the rapidly growing, $1.2 billion market for negative pressure wound therapy via the purchase of BlueSky Medical likely will intensify competition in the treatment category
S&N’s BlueSky Purchase Puts Negative Pressure On Kinetic Concepts
Smith & Nephew's entry into the rapidly growing, $1.2 billion market for negative pressure wound therapy via the purchase of BlueSky Medical likely will intensify competition in the treatment category
Hip Resurfacing Technology Aids S&N Stock Gain In Q1 - Index Up 1.1%
Investor enthusiasm for hip resurfacing's market potential was among factors contributing to Smith & Nephew's 21.3% stock price gain in the first quarter